Related Experiment Video
Updated: May 26, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Cytomegalovirus: recent progress in understanding pathogenesis and control
1Department of Infection (Royal Free Campus), University College London, Rowland Hill Street, Hampstead, London, NW3 2QG, UK. v.emery@ucl.ac.uk
Human cytomegalovirus (HCMV) is a significant pathogen affecting neonates and transplant recipients, contributing to various diseases and early mortality in aging individuals. This review explores recent advancements in understanding HCMV-host interactions and novel therapeutic strategies.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Human cytomegalovirus (HCMV) poses a significant threat to vulnerable populations, including neonates and organ transplant recipients.
- HCMV infection is linked to diverse pathologies, such as inflammatory conditions and increased mortality in aging demographics.
Purpose of the Study:
- To review recent breakthroughs in understanding the intricate interactions between HCMV and its host.
- To discuss emerging therapeutic strategies for controlling HCMV infections.
Main Methods:
- This review synthesizes current research on HCMV pathogenesis and host responses.
- It analyzes novel antiviral therapies and immunomodulatory approaches.
Main Results:
- Advances in understanding HCMV virus-host interactions provide new targets for therapeutic intervention.
- Several promising therapeutic control measures are under investigation.
Conclusions:
- A deeper comprehension of HCMV biology is crucial for developing effective treatments.
- New therapeutic options hold promise for mitigating the impact of HCMV in at-risk patient groups.
Related Concept Videos
Cytomegalovirus Disease
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Viral Hepatitis I: Introduction
Encephalitis ll: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

